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Background: Percutaneous coronary intervention (PCI) is an expensive procedure with proven benefit, but it is unclear whether admitting acute 
myocardial infarction (AMI) patients directly to a PCI facility is more costly on average, given higher procedure rates, than admitting patients to non-
PCI hospitals and accounting for the added cost of transferred patients. We sought to compare Medicare payments for patients admitted with AMI to 
PCI and non-PCI hospitals, including total payments for patients who are transferred as part of the single inpatient episode.
Methods: We identified AMI admissions from January 1 to September 30, 2007, from Medicare fee for service claims data by principal discharge 
diagnosis ICD-9 codes. We measured cost as risk-adjusted Medicare payment, the product of the operating base rate and the diagnosis related 
group weight for each admission, excluding labor and policy adjustments. We combined payments received at all hospitals during a continuous 
episode of inpatient care and attributed them to the initial hospital. We calculated hospital risk-standardized Medicare payment (RSP) using two-
level hierarchical linear regression models that adjust for age, sex, and co-morbidities, and compared volume-weighted average RSPs for PCI and 
non-PCI hospitals. We also measured 30-day risk-standardized mortality rate (RSMR), calculated similarly.
Results: 1,383 PCI and 2,763 non-PCI hospitals were included, with 106,996 (74.5%) and 36,672 (25.5%) admissions, respectively. PCI and 
non-PCI hospitals had similarly distributed RSPs (PCI: mean $11,476, range $9,983-$14,128; non-PCI: mean $11,356, range $10,090-$13,644). 
Patients presenting to PCI hospitals had higher mean PCI rates (39.7% v. 12.8%, P<0.001) and lower mean transfer rates (3.7% v. 26.9%, P<0.001) 
than those presenting to non-PCI hospitals. Mean RSMR was modestly lower in PCI than in non-PCI hospitals (15.9% v. 16.4%, P<0.001).
Conclusion: After accounting for the cost of transferred patients, PCI hospitals do not cost Medicare more than non-PCI hospitals for the care of 
AMI patients, despite higher rates of PCI. However, PCI hospitals do achieve slightly lower 30-day mortality rates.
